Levrett PLC (LON:LVRT), a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, today announced its final results for the
The Directors of Levrett has told DirectorsTalk that the Company has signed a non-binding letter of intent to acquire the entire issued share capital of Nuformix Limited, a UK incorporated
With headlines like this from (Jazz Pharmaceuticals plc – NASDAQ:JAZZ) we knew it wouldn’t go unnoticed by Levrett Plc (LON:LVRT) CEO Pascal Hughes, who we caught up with to ask
Levrett Plc (LON:LVRT), a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, today made the following comment regarding the
Alphabet Inc (NASDAC:GOOGL) executive chairman Eric Schmidt on Monday pointed out six game changing technologies, or what he calls moonshots, that he thinks will improve important parts of society. This
Following on from a previous post on Sean Parker’s cancer initiative – the Parker Institute for Cancer Immunotherapy (PICI) – Fortune Magazine recently published an expansive piece on the thinking
AstraZeneca Plc (LON:AZN) the FTSE 100 drugs giant is currently preparing an offer for coveted American cancer specialist Medivation. DirectorsTalk caught up with Pascal Hughes the CEO of Levrett Plc
Levrett Plc (LON:LVRT) CEO Pascal Hughes, said: “Sean Parker of Napster and Facebook fame joins a list of tech based philanthropists starting initiatives in the Biotech and Lifescience sector with
These are the results for Levrett Plc for the interim period ended 31 December 2015. The company was incorporated on 10 June 2015 and was admitted to the Official
Levrett’s Pascal Hughes discusses the appointment of Whitman Howard a broker, insights from the San Francisco biotech conference and a potential acquisition target in this exclusive interview with DirectorsTalk
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
